Biomarker Partnering and Deal-Making Conference
Register 2, the 3rd goes free with the coupon code rcdvb!
Download the Biomarker Summit 2012 Brochure

Dear Colleague,

GTC is proud to present the Biomarker Partnering and Deal-Making Conference as part of the Biomarker Summit 2012 - the only conference bridging the biomarker scientific and business & investment communities.

Closing in on becoming a $13 billion industry, biomarker advancements require new investments while offering the potential for significant returns. While both developers and investors are seeking the strongest partnerships, only those with the deepest understanding of both scientific and business issues will succeed.

Offering a unique opportunity, the Biomarker Partnering and Deal-Making Conference assembles leading players to discuss what needs to be accomplished to lead the industry into its next phase. The business of biomarkers has reached an exciting and critical stage and intelligence and strategic relationship building is more important than ever. Attendees will be able to set the stage for both at this leading event.

Beyond simply attending a conference, attendees will be part of the larger Biomarker Summit 2012 that also includes:

Biomarker and Diagnostics Conference
4th Oncology Biomarker Conference
6th Biomarker Development Conference

Limitless networking opportunities will be provided for attendees across all four Summit tracks. We look forward to welcoming you to the Biomarker Summit 2012!

The Conference features the following sessions:

Plenary Session

Regulatory & Policy Update: Carolyn Compton, MD, Ph.D., President & CEO, Critical Path Institute

Keynote Speaker: Steven J. Skates, Ph.D., Associate Professor of Medicine, Massachusetts General Hospital Cancer Center

Keynote Speaker: Prof. Dr. med. Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer HealthCare


Biomarker Partnering and Deal-Making Conference

Biomarker Investments in the Current Market (Featured Presentation)

The Necessity of Biomarker Driven Patient Stratification (Featured Presentation)

Roundtable Discussion: Partnership & Investor Panel

Strategic Direction for Biomarker Partnering

Achieving IP on Biomarkers (Presentation)

Roundtable Discussion: Diagnostic Reimbursements in a New Era

Novel Developments in Technology

Models and Trends in Partnering

Kind Regards,

2012 Conference Advisory Committee

Attend ALL 2012 GTCbio Conferences for only $3995 industry rate or $1990 acad/govt rate.
Click here to sign up!

SPONSORS
MEDIA PARTNERS